Drug Shortages Reveal GMP Concerns

Publication
Article
Pharmaceutical TechnologyPharmaceutical Technology-06-02-2002
Volume 26
Issue 6

FDA cites manufacturing difficulties as a main contributing factor to recent drug shortages, which mainly involve injectibles and vaccines.

External Link - article-20204.pdf

Articles in this issue
Excipient GMP Quality Standards: One is Enough
The IPEC-Americas Excipient Master File Guide
Technology Advances Anticounterfeiting Options
Calibration of Lyophilization Pressure Gauges
Drug Shortages Reveal GMP Concerns
Outsourcing Outlook
Optimizing Cross-Organizational Team Performance and Management
Screening for Counterfeit Drugs Using Near-Infrared Spectroscopy
Microencapsulation of Paracetamol by Various Emulsion Techniques Using Cellulose Acetate Phthalate
Building on Tradition: Integrating the Links of Expertise
Recent Videos
Jens Schmidt, associate director MSAT at Lonza
Christian Dunne, director of Global Corporate Business Development at ChargePoint Technology
Related Content
Text sign showing Industry News. Business photo text delivering news to the general public or a target public | Image Credit: © Artur - © Artur - stock.adobe.com

Alvogen Recalls Fentanyl Transdermal System

Susan Haigney
February 3rd 2025
Article

The company is recalling one lot of Fentanyl Transdermal System 25 mcg/h transdermal patches because of possible multi-stacking of patches.

Drug Solutions Podcast: Growth and Advancements in Fill/Finish

Drug Solutions Podcast: Growth and Advancements in Fill/Finish

Felicity Thomas
June 25th 2024
Podcast

In this episode, Hanns-Christian Mahler from ten23 Health chats about the advances in fill/finish.

Text sign showing Industry News. Business photo text delivering news to the general public or a target public | Image Credit: © Artur - © Artur - stock.adobe.com

European Drug Shortage Monitoring Platform Fully Operational

Susan Haigney
January 29th 2025
Article

The platform is live with full functionality for use by marketing authorization holders and national competent authorities to report drug supply information.

Drug Solutions Podcast: All About Data: Looking at the EHDS in More Detail

Drug Solutions Podcast: All About Data: Looking at the EHDS in More Detail

Felicity Thomas
May 28th 2024
Podcast

In this episode, Alexander Natz from EUCOPE chats about the European Health Data Space.

Text sign showing Industry News. Business photo text delivering news to the general public or a target public | Image Credit: © Artur - stock.adobe.com

FDA Warns Sanofi About API CGMP Deviations, Issues Clinical Hold on Atara Immunotherapies

Patrick Lavery
January 23rd 2025
Article

The agency’s newly issued letter to Sanofi amends one sent in December 2024, and stems from inspections at its Massachusetts drug manufacturing facility in June and July 2024.

Text sign showing Industry News. Business photo text delivering news to the general public or a target public | Image Credit: © Artur - © Artur - stock.adobe.com

EMA Prepared for Health Technology Assessment Regulation Implementation

Susan Haigney
January 10th 2025
Article

The HTAR, which aims to increase access to new medicines, becomes effective Jan. 12, 2025.